Non-invasive treatment of bronchial constriction
View Patent ↗Devices, systems and methods for treating bronchoconstriction associated with asthma, anaphylaxis or chronic obstructive pulmonary disease. The treatment comprises transmitting impulses of energy non-invasively to selected nerve fibers that are responsible for smooth muscle dilation, such as the vagus nerve.
1. A device for non-invasively treating a medical condition in a patient comprising:
a power source; and
a container coupled to the power source and comprising an interior filled with a conductive fluid and one or more energy transmission elements within the interior and surrounded by the conductive fluid, the container further comprising a contact surface for contacting a target region on an outer skin surface of a neck of the patient, wherein said one or more energy transmission elements transmits one or more electrical impulses sufficient to stimulate activity of afferent nerve fibers within a vagus nerve of the patient.
2. The device of claim 1 , wherein the source of power supplies a pulse of electric charge to a coil and wherein said coil produces a pulse of magnetic energy when said source of power supplies a pulse of electric charge to said coil, whereby an electric current and/or an electric field can be induced by said pulse of magnetic energy, and whereby energy derived from said induced electric current and/or said induced electric field can stimulate the selected nerve fibers in the patient.
3. The device of claim 2 , further comprising an electrically conducting medium that encloses essentially all of the coil, wherein said conducting medium has a shape that conforms to the contour of a target body surface of the patient when said conducting medium is applied to said target body surface.
4. The device of claim 3 , wherein the target body surface is on a neck of the patient.
5. The device of claim 2 , wherein the coil comprises a toroidal winding around core material having permeability greater than 10% of the permeability of Supermendur.
6. The device of claim 2 , wherein the coil is cooled by a ferrofluid or by a magnetorheological fluid or by a mixture of ferrofluid and magnetorheological fluids.
7. The device of claim 1 , wherein pulses of mechanical or acoustic energy can be transmitted through a target region on a body surface of the patient.
8. The device of claim 7 , wherein energy derived from mechanical and/or acoustical vibrations stimulates the selected nerve fibers, wherein said mechanical and/or acoustical vibration energy is transmitted non-invasively.
9. The device of claim 7 , wherein the target region is on a surface of the neck of the patient.
10. The device of claim 7 , wherein the pulses of mechanical or acoustic energy are generated by a linear actuator, an electromagnet, a bimorph, a piezo crystal, an electrostatic actuator, a speaker coil, crossed ultrasound beams, or a rotating magnet or mass.
11. The device of claim 1 , wherein pulses of light energy or thermal energy can be transmitted through a target region on a surface of the patient.
12. device of claim 11 , wherein energy derived from light or heat stimulates the selected nerve fibers, wherein said light or said heat is transmitted non-invasively.
13. The device of claim 11 , wherein the target region is on the surface of an external auditory meatus of the patient.
14. The device of claim 13 , wherein light energy or thermal energy is transmitted successively from a light source to a light modulator to an earplug and to the target region.
15. The device of claim 11 , that contains a source of light having wavelengths in the range 10 −8 meters to 10 −3 meters, wherein said source of light comprises: a laser, an incandescent bulb, an arc lamp, a fluorescent lamp, a light-emitting diode, a super-luminescent diode, a laser diode, a cathodoluminescent phosphor that is excited by an electron beam, or a light source that is excited by another light source.
16. The device of claim 15 , wherein the source of light has wavelengths in the infrared region of the electromagnetic spectrum.
17. The device of claim 16 , wherein the source of light is a gallium aluminum arsenide laser or a gallium arsenide laser.
18. The device of claim 11 , that contains a light modulator, wherein said light modulator comprises: a movable variable neutral density filter, a mechanical light-chopper wheel, a deformable membrane-mirror, an acousto-optic device, an electro-optic device, a ferroelectric liquid crystal device, a magneto-optic device, a multiple quantum well device, a power source that modulates or switches-on/off power to a light source, rotating crossed polarizers, or a vibrating mirror, diffraction grating, or hologram.
19. The device of claim 1 , wherein the electrical impulses have a frequency of 15 Hz to 50 Hz.
20. The device of claim 1 , wherein the electrical impulses have a frequency of 25 Hz.
21. The device of claim 1 , wherein the electrical impulses has a pulsed on-time of between 50 to 500 microseconds.
22. The device of claim 1 , wherein the electrical impulses has a pulsed on-time of 200-400 microseconds.
23. The device of claim 1 , wherein power of the electrical impulses may vary depending on a magnitude of a surrogate measurement of FEV1, wherein said surrogate measurement is selected from the group consisting of pulsus paradoxus, accessory muscle use, and airway resistance.
24. The device of claim 1 , wherein the medical condition is bronchoconstriction.
25. The device of claim 1 , wherein the conducting fluid is a conducting gel.
26. The device of claim 1 , wherein the conducting fluid contains ferromagnetic particles.
27. The device of claim 1 , wherein the conducting fluid is a magnetorheological fluid.
28. The device of claim 1 , wherein the conducting fluid is a combination of a magnetorheological fluid and a ferrofluid.